ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,368Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 563

$1.57M Total Retail Price of All Prescriptions

Rank: 3 out of 563

556 Patients Receiving at Least One Drug in Part D
22%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 1,713 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$152 was the average price of a prescription from this provider, compared to $135 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
RISPERIDONE 542 35 1 1
QUETIAPINE FUMARATE 420 64 2 5
TRAZODONE HCL 418 62 3 2
CYMBALTA 333 58 4 10
BUPROPION HCL SR 333 49 4 26
ABILIFY 327 74 6 4
BENZTROPINE MESYLATE 310 14 R 7 3
VIIBRYD 307 65 10 8 57
PRISTIQ ER 283 62 9 34
LAMOTRIGINE 278 41 10 8
TOPIRAMATE 269 0 11 32
LITHIUM CARBONATE 258 25 12 15
SERTRALINE HCL 252 50 13 6
ZOLPIDEM TARTRATE 244 38 14 13
DIVALPROEX SODIUM ER 239 27 15 11
OLANZAPINE 222 36 16 12
VENLAFAXINE HCL ER 221 72 17 14
CITALOPRAM HBR 204 64 18 7
FLUOXETINE HCL 196 53 19 9
ESCITALOPRAM OXALATE 190 13 20 18
SEROQUEL 184 26 21 25
ZIPRASIDONE HCL 160 16 22 24
MIRTAZAPINE 148 35 23 16
FLUVOXAMINE MALEATE 144 13 24 53
AMPHETAMINE SALT COMBO 141 28 S2 25 39
NEFAZODONE HCL 128 26 10 26 103
HYDROXYZINE PAMOATE 127 0 R 27 29
BUPROPION XL 127 44 27 17
BUSPIRONE HCL 125 32 29 20
HALOPERIDOL 120 0 30 28
GABAPENTIN 116 16 31 27
CARBIDOPA-LEVODOPA 113 39 32 88
DEXTROAMPHETAMINE SULFATE 103 14 S2 10 33 112
INVEGA 101 0 34 33
CLONAZEPAM 98 49 35 38
PAROXETINE HCL 97 22 36 21
OXCARBAZEPINE 93 0 37 30
PROPRANOLOL HCL 86 0 38 43
ROPINIROLE HCL 82 14 39 68
ALPRAZOLAM 81 23 40 36
SEROQUEL XR 77 0 41 22
CLONIDINE HCL 74 11 42 64
LORAZEPAM 73 38 43 48
LATUDA 67 0 44 41
HYDROXYZINE HCL 66 0 R 45 58
VYVANSE 65 0 S2 46 92
GEODON 56 0 47 56
AMITRIPTYLINE HCL 55 0 R 48 49
NAMENDA 54 38 49 44
METHYLPHENIDATE HCL 53 23 50 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.